Gestational Trophoblastic Disease Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Hydatidiform Mole (HM) Management

• General Information About Gestational Trophoblastic Disease
• Cellular Classification of Gestational Trophoblastic Disease
• Stage Information for Gestational Trophoblastic Disease
• Treatment Option Overview
• Hydatidiform Mole (HM) Management
• Low-Risk Gestational Trophoblastic Neoplasia (FIGO Score 0–6) Treatment
• High-Risk Gestational Trophoblastic Neoplasia (FIGO Score ≥7) Treatment
• Placental-Site Gestational Trophoblastic Tumor Treatment
• Epithelioid Trophoblastic Tumor Treatment
• Recurrent or Chemoresistant Gestational Trophoblastic Neoplasia Treatment
• Changes to This Summary (04 / 12 / 2013)
• About This PDQ Summary
• Get More Information From NCI

1. Kim DS, Moon H, Kim KT, et al.: Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol 67 (5): 690-4, 1986.
2. Limpongsanurak S: Prophylactic actinomycin D for high-risk complete hydatidiform mole. J Reprod Med 46 (2): 110-6, 2001.
3. Uberti EM, Fajardo Mdo C, Ferreira SV, et al.: Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy. Gynecol Oncol 115 (3): 476-81, 2009.